A number of other equities analysts have also weighed in on the company. Cantor Fitzgerald reiterated a buy rating and set a $74.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday. BidaskClub upgraded U.S. Physical Therapy from a sell rating to a hold rating in a research note on Wednesday, October 25th. Zacks Investment Research lowered U.S. Physical Therapy from a hold rating to a sell rating in a research note on Saturday, October 7th. Sidoti upgraded U.S. Physical Therapy from a neutral rating to a buy rating and lifted their price objective for the company from $62.00 to $74.00 in a research note on Friday, September 8th. Finally, Jefferies Group LLC set a $65.00 price objective on U.S. Physical Therapy and gave the company a hold rating in a research note on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. The company has an average rating of Hold and an average price target of $69.00.
Shares of U.S. Physical Therapy (USPH) traded down $1.75 on Friday, reaching $66.30. The company’s stock had a trading volume of 105,690 shares, compared to its average volume of 66,321. The company has a current ratio of 2.04, a quick ratio of 2.26 and a debt-to-equity ratio of 0.30. The company has a market cap of $906.48, a price-to-earnings ratio of 34.81, a PEG ratio of 2.99 and a beta of 1.07.
U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.48 EPS for the quarter, missing the Zacks’ consensus estimate of $0.52 by ($0.04). U.S. Physical Therapy had a return on equity of 10.27% and a net margin of 6.13%. The firm had revenue of $103.03 million for the quarter, compared to analyst estimates of $102.69 million. research analysts forecast that U.S. Physical Therapy will post 2.14 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Shareholders of record on Friday, November 17th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $0.80 annualized dividend and a yield of 1.21%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 48.19%.
In related news, COO Glenn Mcdowell sold 2,598 shares of the company’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $57.00, for a total value of $148,086.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Bernard A. Harris, Jr. sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $62.00, for a total value of $310,000.00. Following the completion of the transaction, the director now owns 26,422 shares in the company, valued at $1,638,164. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,266 shares of company stock valued at $801,134. 3.10% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN lifted its holdings in U.S. Physical Therapy by 2.1% in the second quarter. Wells Fargo & Company MN now owns 45,372 shares of the company’s stock valued at $2,740,000 after acquiring an additional 914 shares during the last quarter. Great Lakes Advisors LLC raised its position in U.S. Physical Therapy by 22.4% in the second quarter. Great Lakes Advisors LLC now owns 26,640 shares of the company’s stock valued at $1,609,000 after purchasing an additional 4,874 shares during the period. Aberdeen Asset Management PLC UK raised its position in U.S. Physical Therapy by 13.4% in the second quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock valued at $42,582,000 after purchasing an additional 83,253 shares during the period. BlackRock Inc. raised its position in U.S. Physical Therapy by 166,319.0% in the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock valued at $101,501,000 after purchasing an additional 1,553,419 shares during the period. Finally, Marshall Wace North America L.P. raised its position in U.S. Physical Therapy by 450.3% in the second quarter. Marshall Wace North America L.P. now owns 19,122 shares of the company’s stock valued at $1,147,000 after purchasing an additional 15,647 shares during the period. Hedge funds and other institutional investors own 94.56% of the company’s stock.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
What are top analysts saying about U.S. Physical Therapy Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for U.S. Physical Therapy Inc. and related companies.